Next report date
Report period
Q3 2024
EPS estimate
1.79EUR
Revenue estimate
1.09 BEUR
5.50EUR
822.89 MEUR
3.87 BEUR
145.92 M
About RESMED INC. DL-,004
Sector
Industry
CEO
Michael J. Farrell
Website
Headquarters
San Diego
Employees (FY)
10.14 K
Founded
1989
FIGI
BBG0080BSP65
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. The firm operates through the Sleep and Respiratory Care and Software as a Service segments. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The Software as a Service segment provides business management software as a service to out-of-hospital health providers. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange RESMED INC. DL-,004 stocks are traded under the ticker RME.
RESMED INC. DL-,004 is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.
RME earnings for the last quarter are 1.55 EUR per share, whereas the estimation was 1.53 EUR resulting in a 1.29% surprise. The estimated earnings for the next quarter are 1.61 EUR per share. See more details about RESMED INC. DL-,004 earnings.
RESMED INC. DL-,004 revenue for the last quarter amounts to 1.04 B EUR despite the estimated figure of 1.04 B EUR. In the next quarter revenue is expected to reach 1.04 B EUR.
Yes, you can track RESMED INC. DL-,004 financials in yearly and quarterly reports right on TradingView.
RME net income for the last quarter is 189.17 M EUR, while the quarter before that showed 207.57 M EUR of net income which accounts for −8.86% change. Track more RESMED INC. DL-,004 financial stats to get the full picture.
Yes, RME dividends are paid quarterly. The last dividend per share was 0.45 EUR. As of today, Dividend Yield (TTM)% is 1.02%. Tracking RESMED INC. DL-,004 dividends might help you take more informed decisions.
RESMED INC. DL-,004 dividend yield was 0.81% in 2023, and payout ratio reached 28.91%. The year before the numbers were 0.80% and 31.69% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, RME shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RESMED INC. DL-,004 stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 10.14 K employees. See our rating of the largest employees — is RESMED INC. DL-,004 on this list?
We've gathered analysts' opinions on RESMED INC. DL-,004 future price: according to them, RME price has a max estimate of 227.78 EUR and a min estimate of 153.95 EUR. Read a more detailed RESMED INC. DL-,004 forecast: see what analysts think of RESMED INC. DL-,004 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RESMED INC. DL-,004 EBITDA is 1.30 B EUR, and current EBITDA margin is 31.93%. See more stats in RESMED INC. DL-,004 financial statements.